ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,003Medicare Part D Prescriptions Filled, Including Refills

Rank: 328 out of 5176

$1.21M Total Retail Price of All Prescriptions

Rank: 165 out of 5176

618 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 618 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

13% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 11,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 720 602 1 3
LEVOTHYROXINE SODIUM 483 439 2 4
ATORVASTATIN CALCIUM 433 400 3 9
METOPROLOL SUCCINATE 385 347 4 11
AMLODIPINE BESYLATE 383 324 5 2
LISINOPRIL 346 284 6 5
ALLOPURINOL 345 319 7 41
HYDROCODONE-ACETAMINOPHEN 342 237 S3 8 27
FUROSEMIDE 259 229 9 8
FLUTICASONE PROPIONATE 243 197 10 38
PRAVASTATIN SODIUM 233 216 11 23
CRESTOR 233 212 11 15
LOSARTAN POTASSIUM 201 177 13 14
ATENOLOL 196 186 14 12
JANUVIA 161 131 15 25
ALENDRONATE SODIUM 160 151 16 18
CARVEDILOL 154 136 17 24
GABAPENTIN 152 114 18 21
ADVAIR DISKUS 137 125 19 32
CITALOPRAM HBR 130 100 20 31
DIOVAN 115 112 21 19
WARFARIN SODIUM 111 96 22 13
HYDROCHLOROTHIAZIDE 110 77 23 10
CYMBALTA 101 81 24 90
TRAMADOL HCL 97 89 25 40
SPIRONOLACTONE 96 86 26 88
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 92 26 49
METFORMIN HCL 94 81 28 7
METOPROLOL TARTRATE 93 88 29 6
SIMVASTATIN 93 68 29 1
PANTOPRAZOLE SODIUM 89 73 31 61
CLOPIDOGREL 87 80 32 26
ZOSTAVAX 86 83 33 219
SYNTHROID 84 82 34 33
NAMENDA 83 83 35 47
NEXIUM 82 63 36 16
TRAZODONE HCL 77 68 37 71
LOVASTATIN 74 70 38 46
PRADAXA 73 67 39 192
PREDNISONE 73 62 39 52
CLONIDINE HCL 71 68 41 79
SPIRIVA 71 63 41 54
METOCLOPRAMIDE HCL 69 41 43 176
ZETIA 69 60 43 68
AZELASTINE HCL 67 60 45 267
SPIRONOLACTONE-HCTZ 67 64 45 253
DONEPEZIL HCL 66 66 47 28
LOSARTAN-HYDROCHLOROTHIAZIDE 65 64 48 35
RANITIDINE HCL 64 59 49 36
BUMETANIDE 63 58 50 209
DOXYCYCLINE HYCLATE 62 52 51 247
ZOLPIDEM TARTRATE 62 61 51 17
POTASSIUM CHLORIDE 61 54 53 34
VERAPAMIL ER 61 61 53 155
PLAVIX 61 56 53 29
POLYETHYLENE GLYCOL 3350 60 56 56 74
TAMSULOSIN HCL 59 58 57 20
AMLODIPINE BESYLATE-BENAZEPRIL 56 51 58 55
DIOVAN HCT 56 56 58 39
PEN NEEDLE 56 50 58 144
CIPROFLOXACIN HCL 55 51 61 84
LOVAZA 54 34 62 43
PROVENTIL HFA 52 51 63 226
CELEBREX 52 52 63 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.